(19)
(11) EP 1 178 798 A1

(12)

(43) Date of publication:
13.02.2002 Bulletin 2002/07

(21) Application number: 00930026.0

(22) Date of filing: 04.05.2000
(51) International Patent Classification (IPC)7: A61K 31/426, A61K 9/00, A61K 47/04, A61P 25/28, A61P 9/10
// C07D277:22
(86) International application number:
PCT/SE0000/876
(87) International publication number:
WO 0067/753 (16.11.2000 Gazette 2000/46)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 06.05.1999 SE 9901658

(71) Applicant: AstraZeneca AB
151 85 Södertälje (SE)

(72) Inventors:
  • CAMBER, Ola
    S-151 85 Södertälje (SE)
  • ELLSTRÖM, Karin
    S-151 85 Södertälje (SE)
  • JÄPPINEN, Ingrid
    S-151 85 Södertälje (SE)
  • PETERSSON-NORDEN, Tomas
    S-151 85 Södertälje (SE)

   


(54) PARENTERAL FORMULATION OF 5-(2-CHLOROETHYL)-4-METHYLTHIAZOLE EDISYLATE(CLOMETHIAZOLE EDISYLATE)